Glaucoma Surgery Explained: Trabeculectomy, MIGS, and What to Expect

When eye drops and laser treatments stop working to control glaucoma, surgery becomes the next step. It’s not about fixing damaged vision-it’s about stopping further loss. The goal is simple: lower eye pressure before it ruins your sight. Two main paths exist today: traditional surgery like trabeculectomy and newer minimally invasive options called MIGS. Both work, but they’re not the same. One is powerful but carries risks. The other is gentle but doesn’t drop pressure as low. Choosing between them isn’t about what’s newer-it’s about what fits your life, your disease stage, and your long-term goals.

What Trabeculectomy Really Does

Trabeculectomy isn’t new. It’s been around since the 1960s, and it’s still the most effective way to slash eye pressure when glaucoma is advanced. The procedure creates a tiny tunnel under the white part of your eye, letting fluid drain out and form a small blister-like pocket called a bleb. This bleb is the key-it’s where the extra fluid collects and gets absorbed by your body, lowering pressure inside the eye.

On average, this surgery cuts eye pressure by 40% to 60%. For someone needing to get their pressure below 15 mmHg-common in advanced glaucoma-it’s often the only option that works. Studies show it succeeds in 85% to 90% of cases at one year. But here’s the catch: it’s intense. The surgery takes about an hour. Recovery isn’t quick. You’ll need 4 to 6 weeks of careful follow-ups, with your doctor checking the bleb, adjusting stitches, or even doing a needle procedure to keep it open. There’s a 10% to 15% chance the bleb will leak. About 1 in 20 people develop a serious infection inside the eye. And over five years, up to 20% of blebs fail.

It’s not for everyone. If you’re young, active, or have other eye conditions, the risks can outweigh the benefits. But if your vision is already at risk and other treatments have failed, this is the procedure that gives you the best shot at holding onto what’s left.

What MIGS Actually Offers

MIGS stands for Minimally Invasive Glaucoma Surgery. It’s a group of tiny procedures-each using tools smaller than a grain of rice-that work with your eye’s natural drainage system. Unlike trabeculectomy, MIGS doesn’t create a bleb. Instead, it opens up blocked channels inside the eye or inserts a microscopic stent to improve fluid flow.

Popular MIGS devices include the iStent inject (two tiny tubes placed in the drainage angle), the Hydrus Microstent (a small metal scaffold that holds the channel open), and the Xen Gel Stent (a soft, 6mm tube that drains fluid under the conjunctiva). These are often done at the same time as cataract surgery, so you’re not having two separate operations.

They don’t drop pressure as much as trabeculectomy-usually 20% to 30%. But that’s often enough. For mild to moderate glaucoma, a target pressure of 15 to 18 mmHg is safe. MIGS achieves that in most patients. The big win? Safety. Complication rates are under 5%. You’re back to normal activities in 1 to 2 weeks. No bleb means no risk of infection from a leak. No long-term monitoring. No daily eye drops to worry about after surgery-most people cut down by 1.5 to 2 medications.

There’s a trade-off: MIGS won’t save you if your pressure is sky-high or your vision is already severely damaged. But if you’re in the early or middle stages, it’s a smart, low-risk move that gives you breathing room.

How Laser Fits Into the Picture

Before you even think about surgery, laser treatment is now the first line of defense. Selective Laser Trabeculoplasty (SLT) uses a gentle laser to stimulate the eye’s drainage system without damaging tissue. It’s quick-5 to 10 minutes. No cuts. No downtime. You can drive home afterward.

The 2023 LiGHT trial changed everything. It showed SLT works just as well as daily eye drops at keeping pressure under control over three years. About 75% of patients stayed within target pressure without needing more treatment. That’s why most eye doctors now start with SLT, not pills. And if it wears off after a few years? You can do it again. No limit.

A newer version, Direct Selective Laser Trabeculoplasty (DSLT), treats the entire drainage angle automatically without touching the eye. It’s faster and easier for the doctor, but it can cause a bit more irritation afterward. Still, it’s another tool to delay or avoid surgery altogether.

Comparing Outcomes: Pressure, Safety, and Recovery

Comparison of Glaucoma Surgeries: Pressure Reduction, Safety, and Recovery

Procedure	Average IOP Reduction	Complication Rate	Recovery Time	Post-op Monitoring
Trabeculectomy	40-60%	5-15%	4-6 weeks	3-6 months
MIGS (e.g., iStent, Xen)	20-30%	1-3%	1-2 weeks	1-2 months
SLT (Laser)	20-30%	Less than 1%	Same day	1-2 visits

These numbers aren’t just stats-they’re life changes. Trabeculectomy gives you the deepest pressure drop, but it demands the most from you. MIGS gives you peace of mind with less hassle. SLT gives you the easiest start. The right choice depends on where you are in your glaucoma journey.

Who Gets Which Surgery?

There’s no one-size-fits-all. Doctors now use a personalized map:

• Early-stage glaucoma: Start with SLT. If pressure creeps up, add MIGS during cataract surgery.
• Moderate glaucoma: MIGS is often the best next step. It reduces medication use and avoids the risks of major surgery.
• Advanced glaucoma: Trabeculectomy or tube shunts are still the go-to. If MIGS didn’t work or pressure is still too high, you’ll likely need the stronger option.
• Younger patients: Trabeculectomy may be preferred because it lasts longer. MIGS results can fade over time.
• Older patients or those with other health issues: MIGS or SLT are safer bets. Less stress on the body, faster recovery.

It’s not about picking the most advanced tech. It’s about matching the tool to the problem. A 45-year-old with rapidly progressing disease needs a durable solution. A 75-year-old with mild glaucoma just needs to avoid eye drops and live comfortably.

Cost and Accessibility

Cost matters-even in countries with public healthcare. Trabeculectomy averages $4,200 per eye. MIGS procedures like the Xen Gel Stent run closer to $6,300 because of the device cost. Tube shunts fall between $5,000 and $7,500. SLT is usually under $1,000.

But here’s the real math: MIGS might cost more upfront, but it often saves money long-term by reducing or eliminating daily eye drops. Those drops can cost $50 to $200 a month. Over five years, that’s $3,000 to $12,000. Plus, fewer office visits for complications.

Insurance covers all these procedures, but approval for MIGS can be trickier. Some insurers still see it as experimental, even though it’s now the standard in 65% of standalone glaucoma surgeries in the U.S. If your doctor recommends MIGS and your insurer denies it, ask for a letter of medical necessity. The data is solid.

The Future Is Personalized

The field is shifting fast. Ten years ago, surgery was a last resort. Today, it’s part of the early plan. Laser, MIGS, and even new drug-delivery implants are being used earlier to slow progression before damage is done.

Suprachoroidal shunts-tiny devices placed between layers of the eye-are showing promise as standalone treatments. Biointerventional techniques are emerging. But the core idea stays the same: treat glaucoma before it steals your vision.

The best outcome isn’t the lowest pressure. It’s the pressure you can live with-without drops, without fear, without more surgery. Whether that’s SLT, MIGS, or trabeculectomy, the goal is simple: protect your sight for as long as possible.

If you’re considering surgery, talk to your doctor about your pressure goals, your lifestyle, and your tolerance for risk. There’s no rush. You have time to weigh your options. The right choice isn’t the most aggressive one-it’s the one that gives you the best chance to keep seeing clearly for years to come.

---